DOI: https://doi.org/10.36347/sajb.2025.v13i08.001

Pages: 1038-1060

Lipid-based nanoparticles (LNPs) have rapidly advanced as adaptable platforms for delivering therapeutic agents with high specificity and temporal precision. Their modular nature enables fine-tuned control over release profiles, making them ideal candidates for treating complex illnesses such as cancers and genetic anomalies. This review proposes a novel conceptual framework—termed the Four-Domain Model—which systematically examines LNP performance across four programmable domains: Architecture, Interface, Payload, and Dispersal. Each domain is explored in light of its chemical tunability, physical behavior, and potential for molecular customization. The model facilitates a comprehensive understanding of LNP interaction with biological environments from formulation to site-specific drug release. The role of kinetic parameters and thermodynamic principles in delivery mechanisms is also critically analyzed. Beyond theoretical design, the article addresses practical hurdles, including manufacturing consistency, upscaling challenges, and regulatory compliance, which collectively influence clinical adoption. Consideration is also given to patient-centered aspects such as optimal dosing schemes, administration methods, and potential side effects. The review further explores alternative delivery routes, notably intranasal and intravenous pathways, evaluating their efficiency and adaptability. A detailed comparison between synthetic LNPs and naturally occurring exosomes is included, highlighting differences in bioavailability, safety, and therapeutic targeting. Altogether, this review envisions the progression of LNPs from synthetic constructs to intelligent, bio-integrative systems capable of maximizing therapeutic efficacy while minimizing off-target interactions.